Inhibition of serum phospholipase-A2 in acute pancreatitis by pharmacological agents in vitro

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 57, Issue 5, 1997, Pages 401-407

  Makela A ^a   Kuusi, T ^a   Schroder T ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Betamethasone; Bupicaine; Chlorpromazine; Dexamethasone; Diclofenac; Digoxin; Doxycycline; Hydrocortisone; Indomethacin; Ketoprofen; Lidocaine; Methylprednisolone; Metoprolol; Pindolol; Propranolol; Tobramycin; Vancomycin

Indexed keywords

BETAMETHASONE; BUPIVACAINE; CHLORPROMAZINE; DEXAMETHASONE; DICLOFENAC; DIGOXIN; DOXYCYCLINE; HYDROCORTISONE; INDOMETACIN; KETOPROFEN; LIDOCAINE; METHYLPREDNISOLONE; METOPROLOL; NONSTEROID ANTIINFLAMMATORY AGENT; PHOSPHOLIPASE A2; PINDOLOL; PROPRANOLOL; TOBRAMYCIN; VANCOMYCIN;

ACUTE HEMORRHAGIC PANCREATITIS; ACUTE PANCREATITIS; ARTICLE; CONTROLLED STUDY; DRUG SCREENING; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME ISOLATION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; PRIORITY JOURNAL;

EID: 0030810422     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365519709084587     Document Type: Article

References (46)

1. 2 dependent mechanisms. Adv Prostaglandin Thromboxane Leukotriene Res 1990; 20: 217-23.
2. 2 regulates critical inflammatory mediators of multiple organ failure. J Surg Res 1994; 56: 199-205.
3. Schmidt H, Creutzfeldt W. The possible role of phospholipase-A in the pathogenesis of acute pancreatitis. Scand J Gastroenterol 1969; 4: 39-48.
4. 2 in acute pancreatitis. Scand J Gastroenterol 1988; 23: 897-904.
5. Holm BA, Keicher L, Liu MY, Sokolowski J, Enhorning G. Inhibition of pulmonary surfactant function by phospholipases. J Appl Physiol 1991; 71: 317-21.
6. Rao KN. Pathophysiology of pancreatitis: the role of prostaglandins. Prostaglandins 1993; 45: 309-13.
7. Gross V, Leser HG, Heinisch A, Scholmerich J. Inflammatory mediators and cytokines - new aspects of the pathophysiology and assessment of severity of acute pancreatitis? Hepatogastroenterology 1993; 40: 522-30.
8. 2 in human acute pancreatitis. Scand J Gastroenterol 1980; 15: 633-6.
9. 2 in human acute pancreatitis. Gastroenterology 1989; 97; 1521-6.
10. Kaiser E, Chiba P, Zaky K. Phospholipases in biology and medicine. Clin Biochem 1990; 23: 349-70.
11. 2 in serum samples from patients with severe acute pancreatitis. Gut 1993; 34: 1133-6.
12. 2 in inflammatory diseases. Clin Chem 1993; 39: 2453-9.
13. 2: causative agent in circulatory collapse of septic shock? Agents Actions 1988; 24: 320-5.
14. 2 activity associated with synovial fluid cells. J Rheumatol 1988; 15: 791-4.
15. 2 inhibitor, in the management of human acute pancreatitis. Scand J Gastroenterol 1985; 20: 5-12.
16. Imrie CW, Benjamin IS, Ferguson JC, et al. A single-centre double-blind trial of Trasylol therapy in primary acute pancreatitis. Br J Surg 1978; 65: 337-41.
17. 2CaEDTA in experimental hemorrhagic pancreatitis in pigs. Scand J Gastroenterol 1987; 22: 35-41.
18. Schröder T, Lempinen M, Nordling S, Kinnunen PK. Chlorpromazine treatment of experimental acute fulminant pancreatitis in pigs. Eur Surg Res 1981; 13: 143-51.
19. Yang CY, Chang-Chien CS, Liaw YF. Controlled trial of protease inhibitor gabexate mesilate (FOY) in the treatment of acute pancreatitis. Pancreas 1987; 2: 698-700.
20. 2 - regulation and inhibition. Klin Wochenschr 1989; 67: 153-9.
21. Niederau C, Schulz HU. Current conservative treatment of acute pancreatitis: evidence from animal and human studies. Hepatogastroenterology 1993; 40: 538-49.
22. 2 activity. Scand J Clin Lab Invest 1987; 47: 529-34.
23. Collery C, editor. Therapeutic drugs 1-2, v. 4. 3rd ed., London: Churchill Livingstone 1991
24. Narang PK, Wilder R, Chatterji DC, Yeager RL, Gallelli JF. Systemic bioavaibility and pharmacokinetics of methylprednisolone in patients with rheumatoid arthritis following "high-dose" pulse administration. Biopharmacol Drug Dispos 1983; 4: 233-48.
25. Petersen MC, Nation RL, McBride WG, Ashley JJ, Moore RG. Pharmacokinetics of betamethasone in healthy adults after intravenous administration. Eur J Clin Pharmacol 1983; 25: 643-50.
26. Toothaker RD, Craig WA, Welling PG. Effect of dose size on the pharmacokinetics of oral hydrocortisone suspension. J Pharm Sci 1982; 71: 1182-5.
27. 2 by non-steroidal anti-inflammatory agents. Modulation by calcium ions. Biochem J 1980; 186: 633-6.
28. 2 activity in carragheenin-induced inflammatory tissue of rats. Biochem Pharmacol 1982; 31: 2993-8.
29. 2 in septic shock. Agents Actions 1986; 19: 194-202.
30. 2 and C in isolated pancreatic islets. Eur J Pharmacol 1982; 86: 121-4.
31. 2 specific inhibitor, in rat carrageenan-induced pleurisy. Inflammation 1993; 17: 107-19.
32. Seeman P. The membrane actions of anesthetics and tranquilizers. Pharmacol Rev 1972; 24: 583-655.
33. Kunze H, Nahas N, Traynor JR, Wurl M. Effects of local anaesthetics on phospholipases. Biochim Biophys Acta 1976; 441: 93-102.
34. 2 by quercetin. Inflammation 1993; 17: 573-82.
35. Fradin A, Rothhut B, Poincelot-Canton B, Errasfa M, Russo-Marie F. Inhibition of eicosanoid and PAF formation by dexamethasone in rat inflammatory polymorphonuclear neutrophils may implicate lipocortin "s". Biochim Biophys Acta 1988; 963: 248-57.
36. 2 as a further possible mechanism of some actions of steroidal anti-inflammatory drugs. Pharmacol Res Commun 1980; 12: 817-27.
37. Kato N, Halprin KM, Matsuo S, Taylor JR. Dexamethasone directly inhibits snake venom phospholipase-A. Biochem Biophys Res Commun 1985; 130: 761-7.
38. Das UN, Padma M, Sagar PS, Ramesh G, Koratkar R. Stimulation of free radical generation in human leukocytes by various agents including tumor necrosis factor is a calmodulin dependent process. Biochem Biophys Res Commun 1990; 167: 1030-6.
39. 2 by cytokines and its prevention by dexamethasone. Adv Exp Med Biol 1992; 318: 1-10.
40. 2. Biochim Biophys Acta 1994; 1224: 541-50.
41. Nagai S, Sugiyama S, Ozawa T. Classification of B- blocking agents by their inhibitory effects on phospholipase-Activity. Jpn Circ J 1986; 50: 238-41.
42. Carlier MB, Laurent G, Tulkens P. In vitro inhibition of lysosomal phospholipases by aminoglycoside antibiotics: a comparative study. Arch Toxicol Suppl 1984; 7: 282-5.
43. 2 on bilayers. Effect of inhibitors. Biochim Biophys Acta 1985; 814: 319-26.
44. 2 by minocycline and doxycycline. Biochem Pharmacol 1992; 44: 1165-70.
45. Kiviniemi H, Rämö OJ, Ståhlberg M, Kairaluoma MI. Indomethacin in canine acute hemorrhagic pancreatitis. Res Exp Med Berl 1988; 188: 35-40.
46. Wildenhain PM, Melhem MF, Birsic WI, Sell HW, Rao KN. Acute hemorrhagic pancreatitis in mice: improved survival after indomethacin administration. Digestion 1989; 44: 41-51.